How many insider trades does FilingIQ track for ALKS?

FilingIQ tracks 1,706 Form 4 insider transactions for ALKS (Alkermes plc.), covering filings from Aug 28, 2013 onwards. 88 of those were filed in the last 90 days.

Are ALKS insiders net buyers or net sellers?

Across the full Form 4 history for ALKS, 7 transactions (0%) were open-market purchases and 302 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ALKS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ALKS in?

Alkermes plc. (ALKS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $5.48B.

ALKS insider trading

Healthcare

Alkermes plc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,706

Last 90 days

Buys / sells

0% / 18%

Market cap

$5.48B

About Alkermes plc.

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Company website: www.alkermes.com

ALKS insider activity at a glance

FilingIQ has scored 1,706 insider transactions for ALKS since Aug 28, 2013. The most recent filing in our index is dated May 4, 2026.

Across the full history, 7 open-market purchases and 302 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ALKS insider trades is 61.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ALKS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ALKS?: FilingIQ tracks 1,706 Form 4 insider transactions for ALKS (Alkermes plc.), covering filings from Aug 28, 2013 onwards. 88 of those were filed in the last 90 days.
Are ALKS insiders net buyers or net sellers?: Across the full Form 4 history for ALKS, 7 transactions (0%) were open-market purchases and 302 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ALKS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ALKS in?: Alkermes plc. (ALKS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $5.48B.

Methodology & sources

Every ALKS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.